These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 14707397)

  • 1. Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study.
    Ochsenkühn T; Marsteller I; Hay U; Diebold J; Paumgartner G; Göke B; Sackmann M
    Digestion; 2003; 68(4):209-16. PubMed ID: 14707397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study.
    Serfaty L; De Leusse A; Rosmorduc O; Desaint B; Flejou JF; Chazouilleres O; Poupon RE; Poupon R
    Hepatology; 2003 Jul; 38(1):203-9. PubMed ID: 12830003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
    van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
    Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonic mucosal proliferation is related to serum deoxycholic acid levels.
    Ochsenkühn T; Bayerdörffer E; Meining A; Schinkel M; Thiede C; Nüssler V; Sackmann M; Hatz R; Neubauer A; Paumgartner G
    Cancer; 1999 Apr; 85(8):1664-9. PubMed ID: 10223558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium and colorectal epithelial cell proliferation in sporadic adenoma patients: a randomized, double-blinded, placebo-controlled clinical trial.
    Bostick RM; Fosdick L; Wood JR; Grambsch P; Grandits GA; Lillemoe TJ; Louis TA; Potter JD
    J Natl Cancer Inst; 1995 Sep; 87(17):1307-15. PubMed ID: 7658483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of vitamin A, C, and E supplementation on rectal cell proliferation in patients with colorectal adenomas.
    Paganelli GM; Biasco G; Brandi G; Santucci R; Gizzi G; Villani V; Cianci M; Miglioli M; Barbara L
    J Natl Cancer Inst; 1992 Jan; 84(1):47-51. PubMed ID: 1738173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients.
    Thompson PA; Wertheim BC; Roe DJ; Ashbeck EL; Jacobs ET; Lance P; Martínez ME; Alberts DS
    Cancer Prev Res (Phila); 2009 Dec; 2(12):1023-30. PubMed ID: 19952360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid.
    Loddenkemper C; Keller S; Hanski ML; Cao M; Jahreis G; Stein H; Zeitz M; Hanski C
    Int J Cancer; 2006 Jun; 118(11):2750-7. PubMed ID: 16385573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
    Alberts DS; Martínez ME; Hess LM; Einspahr JG; Green SB; Bhattacharyya AK; Guillen J; Krutzsch M; Batta AK; Salen G; Fales L; Koonce K; Parish D; Clouser M; Roe D; Lance P;
    J Natl Cancer Inst; 2005 Jun; 97(11):846-53. PubMed ID: 15928305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
    Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
    Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas.
    Nagothu KK; Jaszewski R; Moragoda L; Rishi AK; Finkenauer R; Tobi M; Naumoff JA; Dhar R; Ehrinpreis M; Kucuk O; Majumdar AP
    Cancer Detect Prev; 2003; 27(4):297-304. PubMed ID: 12893078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro.
    Serfaty L
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S53-60. PubMed ID: 23141895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of wheat bran fiber and calcium supplementation on rectal mucosal proliferation rates in patients with resected adenomatous colorectal polyps.
    Alberts DS; Einspahr J; Ritenbaugh C; Aickin M; Rees-McGee S; Atwood J; Emerson S; Mason-Liddil N; Bettinger L; Patel J; Bellapravalu S; Ramanujam PS; Phelps J; Clark L
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):161-9. PubMed ID: 9138658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eicosapentaenoic acid (EPA) reduces crypt cell proliferation and increases apoptosis in normal colonic mucosa in subjects with a history of colorectal adenomas.
    Courtney ED; Matthews S; Finlayson C; Di Pierro D; Belluzzi A; Roda E; Kang JY; Leicester RJ
    Int J Colorectal Dis; 2007 Jul; 22(7):765-76. PubMed ID: 17216221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of deoxycholic acid and butyrate on mucosal prostaglandin E2 release and cell proliferation in the human sigmoid colon.
    Bartram HP; Scheppach W; Englert S; Dusel G; Richter A; Richter F; Kasper H
    JPEN J Parenter Enteral Nutr; 1995; 19(3):182-6. PubMed ID: 8551644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.
    Lindström L; Boberg KM; Wikman O; Friis-Liby I; Hultcrantz R; Prytz H; Sandberg-Gertzén H; Sangfelt P; Rydning A; Folvik G; Gangsøy-Kristiansen M; Danielsson A; Bergquist A
    Aliment Pharmacol Ther; 2012 Feb; 35(4):451-7. PubMed ID: 22221173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of butyrate enemas on gene expression profiles and endoscopic/histopathological scores of diverted colorectal mucosa: A randomized trial.
    Luceri C; Femia AP; Fazi M; Di Martino C; Zolfanelli F; Dolara P; Tonelli F
    Dig Liver Dis; 2016 Jan; 48(1):27-33. PubMed ID: 26607831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid does not affect ethinylestradiol bioavailability in women taking oral contraceptives.
    Baisini O; Benini F; Petraglia F; Kuhnz W; Scalia S; Marschall HU; Brunetti G; Tauschel HD; Lanzini A
    Eur J Clin Pharmacol; 2004 Sep; 60(7):481-7. PubMed ID: 15289960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.